dc.contributor | Wichita State University. Department of Chemistry | en_US |
dc.contributor.author | Groutas, William C. | en_US |
dc.contributor.author | Brubaker, Michael J. | en_US |
dc.contributor.author | Chong, Lee S. | en_US |
dc.contributor.author | Venkataraman, Radhika | en_US |
dc.contributor.author | Huang, He | en_US |
dc.contributor.author | Epp, Jeffrey B. | en_US |
dc.contributor.author | Kuang, Rongze | en_US |
dc.contributor.author | Hoidal, John R. | en_US |
dc.date.accessioned | 2012-02-06T17:15:39Z | |
dc.date.available | 2012-02-06T17:15:39Z | |
dc.date.issued | 1995-04-01 | en_US |
dc.identifier | 8581420 | en_US |
dc.identifier | 9413298 | en_US |
dc.identifier | 096808969500024B | en_US |
dc.identifier | HL 38048 | en_US |
dc.identifier.citation | Bioorganic & medicinal chemistry. 1995 Apr; 3(4): 375-81. | en_US |
dc.identifier.issn | 0968-0896 | en_US |
dc.identifier.uri | http://hdl.handle.net/10057/4247 | |
dc.description | Full text of this article is not available in SOAR. | en_US |
dc.description.abstract | Structure-activity relationship study and in vitro biochemical studies with human leukocyte elastase, cathepsin G and proteinase 3 were conducted using a series of succinimide derivatives. | en_US |
dc.description.sponsorship | NHLBI NIH HHS | en_US |
dc.format.extent | 375-81 | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartofseries | Bioorganic & medicinal chemistry | en_US |
dc.relation.ispartofseries | Bioorg. Med. Chem. | en_US |
dc.source | NLM | en_US |
dc.subject | Research Support, Non-U.S. Gov't | en_US |
dc.subject | Research Support, U.S. Gov't, P.H.S. | en_US |
dc.subject.lcsh | Enzyme Inhibitors/chemistry | en_US |
dc.subject.lcsh | Enzyme Inhibitors/pharmacology | en_US |
dc.subject.lcsh | Succinimides/chemistry | en_US |
dc.subject.lcsh | Succinimides/pharmacology | en_US |
dc.subject.mesh | Amino Acids/chemistry | en_US |
dc.subject.mesh | Cathepsin G | en_US |
dc.subject.mesh | Cathepsins/antagonists & inhibitors | en_US |
dc.subject.mesh | Drug Design | en_US |
dc.subject.mesh | Enzyme Inhibitors/chemical synthesis | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Leukocyte Elastase | en_US |
dc.subject.mesh | Myeloblastin | en_US |
dc.subject.mesh | Pancreatic Elastase/antagonists & inhibitors | en_US |
dc.subject.mesh | Serine Endopeptidases/drug effects* | en_US |
dc.subject.mesh | Serine Proteinase Inhibitors/pharmacology | en_US |
dc.subject.mesh | Structure-Activity Relationship | en_US |
dc.subject.mesh | Succinimides/chemical synthesis | en_US |
dc.subject.mesh | Time Factors | en_US |
dc.title | Design, synthesis and biological evaluation of succinimide derivatives as potential mechanism-based inhibitors of human leukocyte elastase, cathepsin G and proteinase 3 | en_US |
dc.type | Article | en_US |
dc.coverage.spacial | England | en_US |
dc.description.version | peer reviewed | en_US |
dc.rights.holder | Copyright © 1995, Elsevier | en_US |